Answers are grounded in this paper and cite their sources.
Polysaccharide pneumococcal vaccination decreased the risk for some adverse cardiovascular events, specifically acute MI in the vaccinated population, particularly for those individuals aged ≥65 years. It would be highly beneficial to vaccinate the population who is at greater risk of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Marra et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: